Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 12, 2022

SELL
$1.02 - $2.46 $24,104 - $58,134
-23,632 Closed
0 $0
Q4 2021

Feb 10, 2022

SELL
$2.06 - $4.05 $2,401 - $4,722
-1,166 Reduced 4.7%
23,632 $50,000
Q3 2021

Nov 12, 2021

BUY
$3.18 - $5.08 $36,239 - $57,891
11,396 Added 85.03%
24,798 $84,000
Q2 2021

Aug 12, 2021

BUY
$3.83 - $6.31 $51,329 - $84,566
13,402 New
13,402 $54,000
Q1 2021

May 13, 2021

SELL
$4.25 - $12.01 $72,080 - $203,689
-16,960 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$3.21 - $5.68 $54,441 - $96,332
16,960 New
16,960 $72,000

About Calyxt, Inc.


  • Ticker CLXT
  • Exchange NASDAQ
  • Sector Consumer Defensive
  • Industry Packaged Foods
  • Shares Outstandng 46,792,100
  • Market Cap $913M
  • Description
  • Calyxt, Inc., a synthetic biology company, engages in delivering plant-based solutions primarily to the agriculture end market in the United States. The company is involved in the development of improved digestibility alfalfa; hemp; and wheat with a higher fiber content. It has a commercialization agreement with S&W Seed Company for the excl...
More about CLXT
Track This Portfolio

Track Connor, Clark & Lunn Investment Management Ltd. Portfolio

Follow Connor, Clark & Lunn Investment Management Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Connor, Clark & Lunn Investment Management Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Connor, Clark & Lunn Investment Management Ltd. with notifications on news.